The company adds R&D and commercial scale fluid bed technology, OptiMelt hot melt extrusion, at its German facility and elevates cGMP compliance for handling of OEB class 3 customer products.
Catalent Modified Release Technologies president Ian Muir said the expansion follows investments in OSDrC OPTIDOSE optimized controlled release dose delivery technology at Kentucky site and Lyopan fast-dissolve lyophilized tablet technology.